TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Orifarm Generics AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
463,897
|
389,130
|
325,936 |
| Financial expenses |
495
|
189
|
323 |
| Earnings before taxes |
9,750
|
7,610
|
8,523 |
| EBITDA |
9,278
|
6,810
|
5,704 |
| Total assets |
84,091
|
100,967
|
73,931 |
| Current assets |
79,464
|
96,463
|
70,118 |
| Current liabilities |
63,368
|
80,294
|
54,615 |
| Equity capital |
20,722
|
20,673
|
19,316 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
10
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
24.6%
|
20.5%
|
26.1% |
| Turnover per employee |
46,390
|
129,710
|
108,645 |
| Profit as a percentage of turnover |
2.1%
|
2.0%
|
2.6% |
| Return on assets (ROA) |
12.2%
|
7.7%
|
12.0% |
| Current ratio |
125.4%
|
120.1%
|
128.4% |
| Return on equity (ROE) |
47.1%
|
36.8%
|
44.1% |
| Change turnover |
87,638
|
61,515
|
-4,850 |
| Change turnover % |
23%
|
19%
|
-1% |
| Chg. No. of employees |
7
|
0
|
0 |
| Chg. No. of employees % |
233%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.